Bond.az White LogoBond.az Black Logo
→
EN ▾
AZENRU
Intuit cuts 17% of global workforceUS doctor in contact with Ebola patient heading to Czech hospitalWendy's names Robert Wright as new CEOStellantis, JLR to Explore Joint US Vehicle DevelopmentAzerbaijan pavilion captivates tourists at WUF13Gas to be cut in Gabala and Zagatala139 Ebola Deaths: WHO Sounds AlarmDeputy Minister: Principle is to reduce risks before disasterDmitri Mariyasin: Earthquakes Reveal Urban Structural WeaknessesTSX futures rise on inflation worries, Nvidia earningsIntuit cuts 17% of global workforceUS doctor in contact with Ebola patient heading to Czech hospitalWendy's names Robert Wright as new CEOStellantis, JLR to Explore Joint US Vehicle DevelopmentAzerbaijan pavilion captivates tourists at WUF13Gas to be cut in Gabala and Zagatala139 Ebola Deaths: WHO Sounds AlarmDeputy Minister: Principle is to reduce risks before disasterDmitri Mariyasin: Earthquakes Reveal Urban Structural WeaknessesTSX futures rise on inflation worries, Nvidia earnings
Personalize
Bond.az White LogoBond.az Black Logo
AZENRU

#traws-pharma

Latest news and interesting information about traws-pharma.

Traws Pharma Gets $8 Price Target from H.C. Wainwright
Today / 11:40
|
376

Traws Pharma Gets $8 Price Target from H.C. Wainwright

H.C. Wainwright reaffirms Buy on Traws Pharma with $8 target. Financing secured for influenza drug trial. Read more on Bond.az.

ANALYST RATINGS →
0
...